Parallax Volatility Advisers, L.P. Global Blood Therapeutics, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $799,800 - $1.07 Million	-20,000 Reduced 66.67%	10,000 $529,000
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $630,800 - $933,400	20,000 Added 200.0%	30,000 $1.23 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $387,000 - $501,500	10,000 New	10,000 $452,000
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $1.39 Million - $2.31 Million	-35,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $1.04 Million - $1.6 Million	35,000	35,000 $1.38 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.